Next-generation sequencing (NGS) has transformed solid tumor molecular diagnostics by enabling comprehensive genomic profiling. However, traditional NGS workflows are often labor-intensive and ...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today ...
The MarketWatch News Department was not involved in the creation of this content. NATICK, Mass., Nov. 12, 2025 /PRNewswire/ -- Pillar Biosciences, Inc., the leader in Decision Medicine(TM), has ...
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma A retrospective cohort study was conducted at Chris ...
A cancer diagnosis is one of the most dreaded news an individual and their family could receive. In the past, many scientists and clinicians have searched for a definitive cure for cancer. However, ...
Variant detection of multiple genes from a single tumor sample requires high-throughput molecular testing. To meet this demand, targeted next-generation sequencing (NGS) panels are useful in clinical ...
Tumor molecular analysis using next-generation sequencing (NGS) is the standard of care for guiding lung cancer treatment. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) ...
HAYWARD, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Predicine, Inc., a leading molecular insights company, announced the release of its innovative PredicineCARE™ NGS Kit. This offering presents a ...
Precision medicine is key to developing more effective and less toxic treatments, representing the present and future of oncology research. This approach offers significant promise for incremental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback